What To Know About Evercore ISI Group's Downgrade of 1Life Healthcare

Evercore ISI Group downgraded its rating of 1Life Healthcare ONEM to In-Line with a price target of $12.00, changing its price target from $11.00 to $12.00.

Shares of 1Life Healthcare are trading down 7.84% over the last 24 hours, at $10.64 per share.

A move to $12.00 would account for a 12.73% increase from the current share price.

About 1Life Healthcare

1Life Healthcare Inc is a membership-based and technology-powered primary care platform with seamless digital health and inviting in-office care, convenient to where people work, shop, live, and click. Its vision is to provide members with better health and better care while reducing costs. Its mission is to transform healthcare for all through its human-centred, technology-powered model. The company and the One Medical entities do business under the One Medical brand.

About Analyst Ratings

Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along with analyst success scores in Benzinga Pro.

This article was generated by Benzinga's automated content engine and reviewed by an editor.